600521 Zhejiang Huahai Pharmaceutical
- 16.75
- +0.64+3.97%
Zhejiang Huahai Pharmaceutical News
Zhejiang Huahai Pharmaceutical Co., Ltd. Board Audit Committee Performance Report 2023
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the launch of foreign exchange derivatives trading business in 2024
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on adjusting the structure and membership of the special committee of the company's board
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on its subsidiary obtaining drug clinical trial license
Report of the Audit Committee of the Board of Directors of Zhejiang Huahai Pharmaceutical Co., Ltd. on the performance of supervisory duties on accounting firms in 2023
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on amending the company's articles of association and other systems
Zhejiang Huahai Pharmaceutical Co., Ltd. Board of Directors Rules of Procedure
Zhejiang Huahai Pharmaceutical Co., Ltd. Board Audit Committee Working Rules
Working rules for the special meeting of independent directors of Zhejiang Huahai Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd. Accountant Service Selection and Employment System
Notice of Zhejiang Huahai Pharmaceutical Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Zhejiang Huahai Pharmaceutical Co., Ltd. 2023 Internal Control Evaluation Report
Announcement of New Century Rating on the receipt of a warning letter from the Zhejiang Securities Regulatory Bureau by Zhejiang Huahai Pharmaceutical Co., Ltd. and related personnel
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the receipt of a warning letter from the Zhejiang Securities Regulatory Bureau by the company and related personnel
Decision of the Zhejiang Securities Regulatory Bureau on issuing warning letters against Zhejiang Huahai Pharmaceutical Co., Ltd. and related personnel
Zhejiang Huahai Pharmaceutical Co., Ltd. Convertible debt-to-share conversion results and share change announcement
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the disclosure of its 2023 annual report by the holding subsidiary Changxing Pharmaceutical Co., Ltd.
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the change of sponsor representative
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the subsidiary obtaining a drug registration certificate
Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on not revising the “Huahai Bonds” conversion price downward
Analysis
Price Target
No Data
